Spero Therapeutics Inc (SPRO)
1.23
-0.08
(-6.11%)
USD |
NASDAQ |
Nov 14, 13:00
Spero Therapeutics Current Ratio
Current Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Current Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | -- |
| March 31, 2024 | -- |
| December 31, 2023 | -- |
| September 30, 2023 | -- |
| June 30, 2023 | -- |
| March 31, 2023 | -- |
| December 31, 2022 | -- |
| September 30, 2022 | -- |
| June 30, 2022 | -- |
| March 31, 2022 | -- |
| December 31, 2021 | -- |
| September 30, 2021 | -- |
| June 30, 2021 | -- |
| Date | Value |
|---|---|
| March 31, 2021 | -- |
| December 31, 2020 | -- |
| September 30, 2020 | -- |
| June 30, 2020 | -- |
| March 31, 2020 | -- |
| December 31, 2019 | -- |
| September 30, 2019 | -- |
| June 30, 2019 | -- |
| March 31, 2019 | -- |
| December 31, 2018 | -- |
| September 30, 2018 | -- |
| June 30, 2018 | -- |
Current Ratio Definition
Current ratio is measured by current assets/current liabilities. This metric measures how well a company is able to pay short-term liabilties that are on its balance sheet. An attractive current ratio shows that a company's balance sheet is healthy and has solvency.